Lindsay J - Search Results

1

Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention.

Syed AI, Ben-Dor I, Li Y, Collins SD, Torguson R, Wakabayashi K, Gonzalez MA, Maluenda G, Delhaye C, Belle L, Gaglia MA Jr, Xue Z, Kaneshige K, Bernardo N, Kent KM, Suddath WO, Satler LF, Pichard AD, Lindsay J, Waksman R. Syed AI, et al. Among authors: lindsay j. EuroIntervention. 2011 Apr;6(9):1085-90. doi: 10.4244/EIJV6I9A189. EuroIntervention. 2011. PMID: 21518681

2

Device selection in the treatment of in-stent restenosis with and without radiation (from the Gamma Radiation Trials).

Ajani AE, Waksman R, Zimarino M, Kim HS, Pichard AD, Satler LF, Kent KM, White RL, Pinnow E, Mehran R, Lansky A, Lindsay J. Ajani AE, et al. Among authors: lindsay j. Am J Cardiol. 2002 Jan 15;89(2):137-44. doi: 10.1016/s0002-9149(01)02189-0. Am J Cardiol. 2002. PMID: 11792331 Clinical Trial.

3

The outcome of percutaneous coronary intervention in patients with in-stent restenosis who failed intracoronary radiation therapy.

Ajani AE, Waksman R, Cheneau E, Cha DH, McGlynn S, Castagna M, Chan RC, Satler LF, Kent KM, Pichard AD, Pinnow E, Lindsay J. Ajani AE, et al. Among authors: lindsay j. J Am Coll Cardiol. 2003 Feb 19;41(4):551-6. doi: 10.1016/s0735-1097(02)02859-0. J Am Coll Cardiol. 2003. PMID: 12598064 Free article.

4

Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions.

Kinnaird TD, Stabile E, Mintz GS, Lee CW, Canos DA, Gevorkian N, Pinnow EE, Kent KM, Pichard AD, Satler LF, Weissman NJ, Lindsay J, Fuchs S. Kinnaird TD, et al. Among authors: lindsay j. Am J Cardiol. 2003 Oct 15;92(8):930-5. doi: 10.1016/s0002-9149(03)00972-x. Am J Cardiol. 2003. PMID: 14556868

5

Comparison of baseline characteristics and one-year outcomes between African-Americans and Caucasians undergoing percutaneous coronary intervention.

Leborgne L, Cheneau E, Wolfram R, Pinnow EE, Canos DA, Pichard AD, Suddath WO, Satler LF, Lindsay J, Waksman R. Leborgne L, et al. Among authors: lindsay j. Am J Cardiol. 2004 Feb 15;93(4):389-93. doi: 10.1016/j.amjcard.2003.10.029. Am J Cardiol. 2004. PMID: 14969608

6

Impact of intravascular ultrasound-guided direct stenting on clinical outcome of patients treated for native coronary disease.

Cheneau E, Leborgne L, Canos D, Pichard AD, Satler LF, Suddath WO, Kent KM, Lindsay J, Weissman N, Waksman R. Cheneau E, et al. Among authors: lindsay j. Cardiovasc Radiat Med. 2004 Jan-Mar;5(1):15-9. doi: 10.1016/j.carrad.2004.03.005. Cardiovasc Radiat Med. 2004. PMID: 15275627

7

Addition of heparin to contrast media is associated with increased bleeding and peripheral vascular complications during percutaneous coronary intervention with bivalirudin and drug-eluting stents.

Rha SW, Kuchulakanti PK, Pakala R, Cheneau E, Pinnow E, Gebreeyesus A, Aggrey G, Pichard AD, Satler LF, Kent KM, Lindsay J, Waksman R. Rha SW, et al. Among authors: lindsay j. Cardiovasc Radiat Med. 2004 Apr-Jun;5(2):64-70. doi: 10.1016/j.carrad.2004.06.003. Cardiovasc Radiat Med. 2004. PMID: 15464942

8

Bivalirudin versus heparin as an antithrombotic agent in patients treated with a sirolimus-eluting stent.

Rha SW, Kuchulakanti PK, Pakala R, Cheneau E, Fournadjiev JA, Pinnow E, Gebreeyesus A, Aggrey G, Wang Z, Pichard AD, Satler LF, Kent KM, Lindsay J, Waksman R. Rha SW, et al. Among authors: lindsay j. Am J Cardiol. 2004 Oct 15;94(8):1047-50. doi: 10.1016/j.amjcard.2004.06.065. Am J Cardiol. 2004. PMID: 15476623

9

Selective versus exclusive use of sirolimus-eluting stent implantation in multivessel coronary artery disease.

Chu WW, Rha SW, Kuchulakanti PK, Cheneau E, Torguson R, Pakala R, Pinnow EE, Pichard AD, Satler LF, Kent KM, Lindsay J, Waksman R. Chu WW, et al. Among authors: lindsay j. Catheter Cardiovasc Interv. 2005 Aug;65(4):473-7. doi: 10.1002/ccd.20431. Catheter Cardiovasc Interv. 2005. PMID: 15973656

10

Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device.

Rha SW, Kuchulakanti PK, Pakala R, Cheneau E, Pinnow E, Torguson R, Pichard AD, Satler LF, Suddath WO, Kent KM, Lindsay J, Waksman R. Rha SW, et al. Among authors: lindsay j. Am J Cardiol. 2005 Jul 1;96(1):67-70. doi: 10.1016/j.amjcard.2005.02.047. Am J Cardiol. 2005. PMID: 15979436 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,533 results

Search Page